SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Axsome Therapeutics, Inc. with Losses of $500,000 to Contact the FirmNewsfile Corp • 06/13/22
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Axsome Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - AXSMNewsfile Corp • 06/10/22
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Axsome Therapeutics, Inc. with Losses of $500,000 to Contact the FirmNewsfile Corp • 06/10/22
AXSM SHAREHOLDER ALERT: ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Axsome Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - AXSMPRNewsWire • 06/08/22
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Axsome Therapeutics, Inc. with Losses of $500,000 to Contact the FirmNewsfile Corp • 06/08/22
Axsome Therapeutics Announces Results of the SUPPORT Survey of Patients with Major Depressive Disorder Presented at the American Society of Clinical Psychopharmacology Association (ASCP) 2022 Annual MeetingGlobeNewsWire • 06/06/22
AXSM SHAREHOLDER ALERT: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Axsome Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - AXSMNewsfile Corp • 06/03/22
INVESTOR ACTION REMINDER: The Schall Law Firm Encourages Investors in Axsome Therapeutics, Inc. with Losses of $500,000 to Contact the FirmNewsfile Corp • 06/03/22
Axsome Therapeutics Presents New Data from the GEMINI Trial Demonstrating Efficacy of AXS-05 on Anhedonia in Patients with Major Depressive DisorderGlobeNewsWire • 06/02/22
Axsome Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before July 12, 2022 to Discuss Your Rights - AXSMNewsfile Corp • 06/02/22
Axsome Therapeutics, Inc. Investor News: Robbins LLP is Investigating Axsome Therapeutics, Inc. (AXSM) on Behalf of ShareholdersBusiness Wire • 06/01/22
INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Axsome Therapeutics, Inc. with Losses of $500,000 to Contact the FirmNewsfile Corp • 06/01/22
ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages Axsome Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - AXSMPRNewsWire • 05/31/22
Axsome Therapeutics Announces Publication of Pivotal GEMINI Phase 3 Trial of AXS-05 in Major Depressive Disorder in The Journal of Clinical PsychiatryGlobeNewsWire • 05/31/22
AXSM LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Axsome Therapeutics, Inc.Newsfile Corp • 05/31/22
Shareholder Alert: Pomerantz Law Firm Reminds Shareholders with Losses on Their Investment in Axsome Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - AXSMNewsfile Corp • 05/28/22
INVESTOR DEADLINE: Investors in Axsome Therapeutics, Inc. with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - AXSMNewsfile Corp • 05/27/22
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Axsome Therapeutics, Inc. (AXSM)Business Wire • 05/26/22
Axsome Therapeutics, Inc. CLASS ACTION Alert: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against Axsome Therapeutics, PRNewsWire • 05/26/22
AXSM INVESTOR NOTICE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Axsome Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - AXSMPRNewsWire • 05/24/22
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Axsome Therapeutics, Inc. (AXSM)Business Wire • 05/24/22
INVESTOR ALERT: Investors in Axsome Therapeutics, Inc. with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - AXSMNewsfile Corp • 05/24/22
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Axsome Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – AXSMBusiness Wire • 05/23/22
